Clinical Trials Browser

Interventional × etaracizumab × Genitourinary × Clear all

NCT00684996 2014-05-15

Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 1/2 Terminated

5 enrolled 7 charts

Carcinoma, Renal Cell

NCT00072930 2008-01-15

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms